Monoclonal antibodies in cancer immunotherapy I Kimiz-Gebologlu, S Gulce-Iz, C Biray-Avci Molecular biology reports 45 (6), 2935-2940, 2018 | 219 | 2018 |
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake I Kimiz-Gebologlu, SS Oncel Journal of Controlled Release 347, 533-543, 2022 | 211 | 2022 |
A bilayer scaffold prepared from collagen and carboxymethyl cellulose for skin tissue engineering applications C Kilic Bektas, I Kimiz, A Sendemir, V Hasirci, N Hasirci Journal of Biomaterials Science, Polymer Edition 29 (14), 1764-1784, 2018 | 43 | 2018 |
Screening of antioxidant and cytotoxic activities of several microalgal extracts with pharmaceutical potential C Gürlek, Ç Yarkent, A Köse, B Tuğcu, I Kımız-Geboloğlu, SŞ Öncel, ... Health and Technology 10, 111-117, 2020 | 33 | 2020 |
Delivery of pemetrexed by magnetic nanoparticles: design, characterization, in vitro and in vivo assessment G Ak, D Aksu, E Çapkın, Ö Sarı, I Kımız Geboloğlu, ŞH Şanlıer Preparative Biochemistry & Biotechnology 50 (3), 215-225, 2020 | 13 | 2020 |
The use of Toxoplasma gondii tachyzoites produced in HeLa cells adhered to Cytodex 1 microcarriers as antigen in serological assays: an application of … P Sağlam Metiner, H Can, D Ayyıldız Tamiş, M Karakavuk, ... Cytotechnology 71, 91-105, 2019 | 10 | 2019 |
Influenza vaccine: an engineering vision from virological importance to production SF Demirden, K Alptekin, I Kimiz-Gebologlu, SS Oncel Biotechnology and Bioprocess Engineering 27 (5), 740-764, 2022 | 6 | 2022 |
Development of a serum free medium for HUMIRA® biosimilar by design of experiment approaches I Kimiz-Gebologlu, P Saglam-Metiner, O Ozaslan, D Ayyildiz-Tamis, ... Turkish Journal of Biochemistry 45 (3), 283-294, 2020 | 6 | 2020 |
Polyclonal Antibody Production Against Hapten Structured KDN Molecule by Using Different Adjuvants Alternative to Freund’s Adjuvant SG İz, PS Metiner, Ç Kayalı, SİD Gürhan European Journal of Therapeutics 24 (2), 106-111, 2018 | 5 | 2018 |
A study of the THP‐1 cell line as the potential biologics production platform with the emphasis on serum‐free media substitution for economic expediency I Kimiz‐Gebologlu, SF Demirden, SS Oncel Biotechnology Journal 17 (9), 2200154, 2022 | 3 | 2022 |
New developments in supercritical fluids as a green technology: Processing of β-glucanase with sub-and supercritical carbon dioxide D Senyay-Oncel, I Kimiz-Gebologlu, O Yesil-Celiktas Biochemical Engineering Journal 195, 108934, 2023 | 2 | 2023 |
Dünden Bugüne Türkiye’de Aşılama ve Aşı Üretiminin Tarihçesi SF Demirden, K Alptekin, IK Geboloğlu, SŞ Öncel Türk Mikrobiyoloji Cemiyeti Dergisi, 247, 2022 | 1 | 2022 |
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective SF Demirden, I Kimiz-Gebologlu, SS Oncel ACS omega 9 (15), 16904-16926, 2024 | | 2024 |
Importance of Intellectual Property Rights for Building a Sustainable Future SF Demirden, I Kimiz-Gebologlu, K Alptekin, D Senyay-Oncel A Sustainable Green Future: Perspectives on Energy, Economy, Industry …, 2023 | | 2023 |
ICABB 2018 SI Deliloglu-Gurhan, P Saglam-Metiner, I Kimiz-Gebologlu, S Gulce-Iz | | 2018 |
Oral Presentation-9 P Saglam-Metiner, I Kimiz-Gebologlu, SS Oncel, O Yesil-Celiktas | | |
History of vaccination and vaccine production in Türkiye: From past to present SF Demirden, K Alptekin, IK Geboloğlu, SŞ Öncel | | |